Market Research Logo

Namibia Pharmaceuticals and Healthcare Report Q2 2016

Namibia Pharmaceuticals and Healthcare Report Q2 2016

BMI View: The vast majority of Namibia's pharmaceutical needs will remain sourced from abroad,however, domestic production of ARV drug nevirapine shows a commitment to achieving self-sufficiency interms of medicine production. However, this is unlikely to be achieved in the foreseeable future given thelimited production capacity among domestic companies including Fabupharm.

Headline Expenditure Forecasts

Pharmaceuticals: NAD2.34bn (USD184mn) in 2015 to NAD2.56bn (USD172mn) in 2016; +9.4% inlocal currency and -6.5% in US dollar terms. Forecast unchanged from last quarter in local currencyterms and revised downwards in USD terms.

Healthcare: NAD11.38bn (USD895mn) in 2015 to NAD12.48bn (USD840mn) in 2016; +9.7% in localcurrency and -6.2% in US dollar terms. Forecast revised slightly upwards from last quarter in localcurrency terms and downwards in USD terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Namibia 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Namibia 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Namibia 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Namibia 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Namibia 2012-2020)
Industry Risk Reward Index
Middle East and Africa Risk/Reward Index - Q2 2016
Namibia Risk/Reward Index
Rewards
Risks
Regulatory Review
Pharmaceutical Distribution
Market Overview
Healthcare Sector
Research & Development
Epidemiology
Demographic Forecast
Namibia - Demographic Forecast
Table: Population Headline Indicators (Namibia 1990-2025)
Table: Key Population Ratios (Namibia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Namibia 1990-2025)
Table: Population By Age Group (Namibia 1990-2025)
Table: Population By Age Group % (Namibia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report